Vaccine
Pfizer/BioNTech vaccine side effects feel like a “severe hangover”
November 12, 2020Business Services COVID, Vaccine, coronavirus
Clinical trial participants receiving the Pfizer/BioNTech coronavirus vaccine have said it created side effects that felt similar to a “severe …
First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine
November 11, 2020Research and Development COVID-19, Russia, Sputnik V, Vaccine
The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …
Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis
November 10, 2020Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …
Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni
November 9, 2020Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine
AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
Australia secures a further 50m COVID-19 vaccine doses from Novavax and Pfizer/BioNTech
November 5, 2020Manufacturing and Production Australia, COVID-19, Vaccine
Two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to …
Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan
October 29, 2020Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine
Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …
AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants
October 26, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine
AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …
Spain secures 31.6 million doses of AstraZeneca’s COVID-19 vaccine
October 21, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Spain, Vaccine
AstraZeneca continues to forge agreements with national governments to deliver its vaccine against COVID-19, with Spain becoming the latest country …
Pfizer won’t apply for COVID-19 vaccine emergency authorisation until after US election, CEO says
October 19, 2020Sales and Marketing COVID-19, Pfizer, US, Vaccine
The Chief Executive Officer of Pfizer has said that the company will now submit their vaccine for FDA Emergency Use …
Russia gives regulatory approval to second COVID-19 vaccine after early clinical trials
October 15, 2020Research and Development COVID Vaccine, Vaccine, coronavirus vaccine
Russian President Vladimir Putin announced on Wednesday that regulators had given approval to a second coronavirus vaccine. This new vaccine …
J&J halts COVID-19 vaccine study following unidentified participant illness
October 13, 2020Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma
Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine
October 7, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …
White House halts release of new FDA standards for the Emergency Use Authorization of COVID-19 vaccine
October 6, 2020Manufacturing and Production FDA, Trump, Vaccine, coronavirus vaccines
The Trump White House is blocking new federal guidance for the emergency release of coronavirus vaccines that would essentially ensure …
IGT Biologika’s COVID-19 vaccine becomes third in Germany to be approved for human trials
October 2, 2020Medical Communications, Research and Development COVID-19, IDT Biologika, Vaccine
German biotech IDT Biologika has become the third company in the country to secure approval from the nation’s vaccine regulator …
GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU
September 25, 2020Manufacturing and Production, Medical Communications COVID-19, EU, GSK, Vaccine
GlaxoSmithKline has confirmed a new COVID-19 vaccine supply deal to deliver 300 million doses of its candidate to the European …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
